| Size & multiples | |||
| Market Cap | ₩39.07T | Enterprise Value | — |
| P/E (TTM) | 38.35× | PEG (trailing) | 5.02× |
| P/S | 9.39× | P/FCF | 72.64× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 1.38% | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.35 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.75% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM ₩4660.00 · revenue TTM ₩4.16T · FCF TTM ₩537.83B (in KRW)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E
P/E 74th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 38.3x | 24.4x | 13.0x–39.3x | 74 ↑rich |
| FCF Yield | 1.4% | -7.8% | -34.7%–1.4% | 74 ↑strong |
| Dividend Yield | 0.4% | 1.1% | 0.2%–2.4% | 29 ↓weak |
| Net Margin | 24.7% | -21.2% | -325.3%–7.2% | 91 ↑strong |
| Operating Margin | 28.1% | -34.5% | -552.0%–8.0% | 95 ↑strong |
| ROE | 5.9% | -36.8% | -92.5%–4.5% | 76 ↑strong |
